Patents-Review.com
ClassID:

110788 ⎘

C12N2760/16021 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae Viruses as such, e.g. new isolates, mutants or their genomic sequences

Recent Application in this class:
#1
20250255953
2025-08-14

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS

 #2
20240398930
2024-12-05

A VACCINE FOR CORONAVIRUS AND INFLUENZA VIRUS, AND METHOD FOR PREPARATION THEREOF

 #3
20240076632
2024-03-07

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS

 #4
20240044048
2024-02-08

BARCODED INFLUENZA VIRUSES AND DEEP MUTATIONAL SCANNING LIBRARIES INCLUDING THE SAME

 #5
20230332174
2023-10-19

NUCLEIC ACID CONSTRUCT, RECOMBINANT INFLUENZA VIRUS, METHOD FOR PREPARING A RECOMBINANT INFLUENZA VIRUS, COMPOSITION AND USE

 #6
20230174996
2023-06-08

REASSORTED ISA VIRUS

 #7
20220202927
2022-06-30

Recombinant influenza viruses with stabilized HA for replication in eggs

 #8
20210147832
2021-05-20

Barcoded influenza viruses and deep mutational scanning libraries including the same

 #9
20210102178
2021-04-08

Recombinant influenza viruses with stabilized HA for replication in eggs

 #10
20200268870
2020-08-27

Mutant virus, preparation method therefor and application thereof

 #11
20200239858
2020-07-30

RECOMBINANT VECTORS

 #12
20190284575
2019-09-19

REVERSE GENETICS USING NON-ENDOGENOUS POL I PROMOTERS

 #13
20190167781
2019-06-06

Recombinant influenza viruses with stabilized HA for replication in eggs

 #14
20180177863
2018-06-28

Methods of making and using live attenuated viruses

 #15
20180087035
2018-03-29

Recombinant vectors

 #16
20180030416
2018-02-01

Plasmids and method for obtaining viral particles

 #17
20170122933
2017-05-04

Method for rapidly designing pharmaceutical preparations for preventing viral infection

 #18
20160053232
2016-02-25

Recombinant vectors

 #19
20160024525
2016-01-28

REVERSE GENETICS USING NON-ENDOGENOUS POL I PROMOTERS

 #20
20160002606
2016-01-07

Method for influenza virus purification

 #21
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #22
20150275186
2015-10-01

Production of viral vaccines in suspension on avian embryonic derived stem cell lines

 #23
20140377308
2014-12-25

METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES

 #24
20140227310
2014-08-14

RECOMBINANT INFLUENZA VIRUS HIGHLY EXPRESSING HA PROTEIN AND PREPARATION METHOD AND USE THEREOF

 #25
20120238001
2012-09-20

Production of viral vaccines in suspension on avian embryonic derived stem cell lines

 #26
20120189656
2012-07-26

Reverse genetics using non-endogenous pol I promoters

 #27
20110287020
2011-11-24

Recombinant vectors

 #28
20110223199
2011-09-15

Method for production of pH stable enveloped viruses

 #29
20100172934
2010-07-08

Method for production of pH stable enveloped viruses

 #30
20100158944
2010-06-24

Method for influenza virus protection

 #31
20090081251
2009-03-26

Production of viral vaccines in suspension on avian embryonic derived stem cell lines

 #32
20090074812
2009-03-19

Influenza M2 protein mutant viruses as live influenza attenuated vaccines

 #33
20080050403
2008-02-28

Production of viruses, viral isolates and vaccines

 #34
20050123564
2005-06-09

Production of viruses viral isolates and vaccines